BioPharmX to Present at Oppenheimer's 28th Annual Healthcare Conference

MENLO PARK, Calif., March 14, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing dermatology products, today announces that it will present its updated corporate presentation at Oppenheimer's 28^th Annual Healthcare Conference in New York, where it will also be webcast live.

BioPharmX President and Co-founder Anja Krammer, will present the company's updated overview at the conference on Wednesday, March 21, at 10:55 a.m. EDT at The Westin New York Grand Central.

The live webcast will be available at https://www.veracast.com/webcasts/opco/healthcare2018/47207475132.cfm and a replay will be accessible for 90 days following the presentation.

Oppenheimer's Annual Healthcare Conference hosts a broad spectrum of public and private companies who are leaders and pioneers in the biopharmaceutical, biotechnology, medical device, life science tools & diagnostics, health technology & distribution, and healthcare facility, provider and service industries.  It is anticipated, once again, to be one of the most important investor conferences in this sector.

About BioPharmX^® Corporation
BioPharmX Corporation (NYSE American: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit www.BioPharmX.com.

BioPharmX is a registered trademark of BioPharmX, Inc.

View original content with multimedia:http://www.prnewswire.com/news-releases/biopharmx-to-present-at-oppenheimers-28th-annual-healthcare-conference-300611590.html

SOURCE BioPharmX Corporation